Geode Capital Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-948,159
| Closed | -$1.1M | – | 5101 |
|
|
2022
Q2 | $1.1M | Sell |
948,159
-696,318
| -42% | -$728K | ﹤0.01% | 3381 |
|
|
2022
Q1 | $1.78M | Sell |
1,644,477
-68,937
| -4% | -$52.1K | ﹤0.01% | 3307 |
|
|
2021
Q4 | $1.23M | Buy |
1,713,414
+7,915
| +0.5% | +$6.4K | ﹤0.01% | 3604 |
|
|
2021
Q3 | $1.54M | Sell |
1,705,499
-13,567
| -0.8% | -$16.3K | ﹤0.01% | 3475 |
|
|
2021
Q2 | $2.85M | Buy |
1,719,066
+299,945
| +21% | +$501K | ﹤0.01% | 3157 |
|
|
2021
Q1 | $2.96M | Buy |
1,419,121
+614,747
| +76% | +$1.28M | ﹤0.01% | 3063 |
|
|
2020
Q4 | $1M | Buy |
804,374
+29,268
| +4% | +$34.9K | ﹤0.01% | 3370 |
|
|
2020
Q3 | $945K | Buy |
775,106
+2,276
| +0.3% | +$2.77K | ﹤0.01% | 3235 |
|
|
2020
Q2 | $904K | Buy |
772,830
+181,865
| +31% | +$168K | ﹤0.01% | 3169 |
|
|
2020
Q1 | $482K | Buy |
590,965
+53,374
| +10% | +$56.6K | ﹤0.01% | 3286 |
|
|
2019
Q4 | $542K | Buy |
537,591
+8,281
| +2% | +$10K | ﹤0.01% | 3471 |
|
|
2019
Q3 | $746K | Buy |
529,310
+726
| +0.1% | +$1.02K | ﹤0.01% | 3342 |
|
|
2019
Q2 | $792K | Buy |
528,584
+59,543
| +13% | +$92.1K | ﹤0.01% | 3302 |
|
|
2019
Q1 | $717K | Buy |
469,041
+25,430
| +6% | +$38.8K | ﹤0.01% | 3294 |
|
|
2018
Q4 | $652K | Buy |
443,611
+24,460
| +6% | +$37.5K | ﹤0.01% | 3271 |
|
|
2018
Q3 | $767K | Buy |
419,151
+89,223
| +27% | +$173K | ﹤0.01% | 3319 |
|
|
2018
Q2 | $607K | Buy |
329,928
+240,518
| +269% | +$448K | ﹤0.01% | 3368 |
|
|
2018
Q1 | $178K | Hold |
89,410
| – | – | ﹤0.01% | 3722 |
|
|
2017
Q4 | $98K | Hold |
89,410
| – | – | ﹤0.01% | 3821 |
|
|
2017
Q3 | $102K | Hold |
89,410
| – | – | ﹤0.01% | 3824 |
|
|
2017
Q2 | $115K | Buy |
89,410
+14,926
| +20% | +$21.2K | ﹤0.01% | 3814 |
|
|
2017
Q1 | $145K | Hold |
74,484
| – | – | ﹤0.01% | 3744 |
|
|
2016
Q4 | $159K | Hold |
74,484
| – | – | ﹤0.01% | 3689 |
|
|
2016
Q3 | $128K | Hold |
74,484
| – | – | ﹤0.01% | 3742 |
|
|
2016
Q2 | $61K | Sell |
74,484
-2,017
| -3% | -$1.56K | ﹤0.01% | 3897 |
|
|
2016
Q1 | $68 | Sell |
76,501
-61
| -0.1% | -$61 | ﹤0.01% | 3917 |
|
|
2015
Q4 | $84K | Buy |
76,562
+122
| +0.2% | +$261 | ﹤0.01% | 3926 |
|
|
2015
Q3 | $161K | Buy |
76,440
+80
| +0.1% | +$156 | ﹤0.01% | 3759 |
|
|
2015
Q2 | $151K | Sell |
76,360
-12,082
| -14% | -$34.3K | ﹤0.01% | 3665 |
|
|
2015
Q1 | $342K | Buy |
88,442
+8,707
| +11% | +$32.2K | ﹤0.01% | 3358 |
|
|
2014
Q4 | $287K | Buy |
79,735
+183
| +0.2% | +$484 | ﹤0.01% | 3428 |
|
|
2014
Q3 | $211K | Buy |
79,552
+3,575
| +5% | +$23.9K | ﹤0.01% | 3550 |
|
|
2014
Q2 | $882K | Buy |
75,977
+46,105
| +154% | +$522K | ﹤0.01% | 2869 |
|
|
2014
Q1 | $417K | Sell |
29,872
-218
| -0.7% | -$3.42K | ﹤0.01% | 3228 |
|
|
2013
Q4 | $535K | Buy |
30,090
+1,886
| +7% | +$30.6K | ﹤0.01% | 3060 |
|
|
2013
Q3 | $475K | Buy |
+28,204
| New | +$396K | ﹤0.01% | 2980 |
|
Geode Capital Management's MBII Position: Q3 2022 in Review
Geode Capital Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 948,159 shares — an estimated $1.1M sold.
Geode Capital Management first reported a position in MBII in Q3 2013 and held it in 36 quarters. The position peaked at $2.96M in Q1 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- Geode Capital Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- Geode Capital Management sold 948,159 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $1.1M.
- Geode Capital Management first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 36 quarters.
- Geode Capital Management's Marrone Bio Innovations, Inc. position peaked at $2.96M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on Geode Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.